Denali Therapeutics Inc. (DNLI) Marketable Securities, Current USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Denali Therapeutics Inc. quarterly Marketable Securities, Current history and growth rate from 2017 to 2024.
  • Denali Therapeutics Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $876 M, a 28.2% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $876 M -$344 M -28.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $907 M -$211 M -18.8% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $961 M -$26.2 M -2.65% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.06 B +$145 M +15.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.22 B +$368 M +43.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.12 B +$546 M +95.5% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $987 M +$343 M +53.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $914 M +$90.3 M +11% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $853 M -$125 M -12.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $572 M -$391 M -40.6% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $645 M +$34.5 M +5.65% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $823 M +$411 M +99.6% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $978 M +$598 M +158% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $963 M +$627 M +187% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $610 M +$213 M +53.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $412 M -$3.27 M -0.79% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $380 M -$66.1 M -14.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $336 M -$51.3 M -13.2% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $397 M +$65.4 M +19.7% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $416 M +$76.2 M +22.4% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $446 M +$116 M +35.3% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $387 M +$199 M +106% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $331 M Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $340 M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $329 M Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $188 M Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.